Falsified Medical Product Alert N°4/2021

Remdesivir injection 100mg/20ml (5mg/ml): falsified product alert

WHO issued this alert on two falsified batches of remdesivir reported to WHO in July 2021 at patient level, including at a hospital, in Mexico. The products were illicitly supplied on the internet. The batch numbers do not match any GILEAD remdesivir.¹

Health risk as statedNo explicit health risk statement on the alert page. WHO said the composition of the vials was unknown and laboratory analyses were to be conducted.

Issued: 13 August 2021
Issued by: World Health Organization
Name stated on packaging: GILEAD, stated on the packaging. WHO said the products claim to be manufactured by GILEAD.
Genuine manufacturer's statement: WHO said GILEAD confirmed the remdesivir products listed in the alert are falsified and were not manufactured by them.
Countries where detected: Mexico

Batches named in the alert

EN2005A2-B (expiry 06/2023), EN2009D7-Q

Advice as stated

Do not use the listed products. Obtain medicines only from authorised or licensed suppliers and check their authenticity and condition. Report adverse events or suspected falsification to the national regulatory authority or pharmacovigilance centre.

Names printed on falsified products are not evidence that the named company made them. Where WHO or a regulator reports the genuine manufacturer's statement, it is shown.

Sources

World Health Organization, Medical Product Alert N°4/2021: Falsified remdesivir (13 August 2021)